| Bioactivity | Anticancer agent 175 (complex 1) ia a near-infrared (NIR) luminescent theranostic complex. Anticancer agent 175 induces ROS accumulation, mitochondrial damage, disruption of Bax/Bcl-2 equilibrium, and tumor cell apoptosis in HepG2 cell line[1]. |
| Name | Anticancer agent 175 |
| Formula | C81H86F10IrN8O4P- |
| Molar Mass | 1648.78 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang L, et al. A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability. Eur J Med Chem. Published online November 25, 2023. |
Anticancer agent 175
CAS: F: C81H86F10IrN8O4P- W: 1648.78
Anticancer agent 175 (complex 1) ia a near-infrared (NIR) luminescent theranostic complex. Anticancer agent 175 induces
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.